Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

The Health Insurance Corp. (PhilHealth) has increased its coverage for open heart surgeries to almost P1 million and also ...

Serious heart problems kept one local senior from dancing with his wife. But thanks to a life-saving procedure at White ...

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Sanofi's experimental drug ataciguat has shown promise in reducing the progression of aortic valve stenosis in clinical trials, potentially delaying the need for surgical valve replacement. With ...

Q: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...

“Heart valve disease often goes undetected until it becomes serious, but early diagnosis can make all the difference,” said ...

Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

Sue Dumbauld got an alert from her Apple Watch that her heart rate was dangerously high. This inspired her to exercise ahead ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...